# Phathom Pharmaceuticals, Inc.: filings

PHAT · Nasdaq · CIK 1783183 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/phat.md) · [Financials](/companies/phat/financials.md) · [Filings](/companies/phat/filings.md) · [Insiders](/companies/phat/insiders.md)

## Reports and events: 155 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 173, 8-K 102, 3 23, 10-Q 22, SC 13G/A 15, SC 13G 9, 424B5 8, DEFA14A 8, SC 13D/A 8, 10-K 7, DEF 14A 7, CORRESP 6, SCHEDULE 13G/A 6, UPLOAD 6, S-8 5, ARS 4, SEC STAFF LETTER 4, 4/A 3, EFFECT 3, SCHEDULE 13D/A 3, 10-Q/A 2, DRSLTR 2, S-3 2, SCHEDULE 13G 2, 10-K/A 1, 3/A 1, 424B4 1, 5 1, 8-A12B 1, CERT 1, DRS 1, DRS/A 1, FWP 1, PRE 14A 1, S-1 1, S-1/A 1, S-1MEF 1, S-3ASR 1, SC 13D 1, SC TO-C 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 07:05 ET | [10-Q](/filings/0001193125-26-436961.md) | Quarterly report, period 2026-09-30 | 0001193125-26-436961 |
| 2026-10-29 | 07:05 ET | [8-K](/filings/0001193125-26-436959.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-436959 |
| 2026-10-26 | 06:02 ET | [8-K](/filings/0001193125-26-430977.md) | 8.01 Other events | 0001193125-26-430977 |
| 2026-10-23 | 17:00 ET | [8-K](/filings/0001193125-26-430621.md) | 8.01 Other events | 0001193125-26-430621 |
| 2026-09-29 | 16:45 ET | [8-K](/filings/0001193125-26-407696.md) | 8.01 Other events | 0001193125-26-407696 |
| 2026-07-30 | 07:05 ET | [10-Q](/filings/0001193125-26-324867.md) | Quarterly report, period 2026-06-30 | 0001193125-26-324867 |
| 2026-07-30 | 07:05 ET | [8-K](/filings/0001193125-26-324865.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-324865 |
| 2026-06-23 | 08:00 ET | [8-K](/filings/0001193125-26-278533.md) | 8.01 Other events | 0001193125-26-278533 |
| 2026-05-21 | 16:01 ET | [8-K](/filings/0001193125-26-234379.md) | 5.07 Shareholder vote results | 0001193125-26-234379 |
| 2026-04-30 | 07:05 ET | [10-Q](/filings/0001193125-26-193946.md) | Quarterly report, period 2026-03-31 | 0001193125-26-193946 |
| 2026-04-30 | 07:05 ET | [8-K](/filings/0001193125-26-193945.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-193945 |
| 2026-04-07 | 08:00 ET | [DEF 14A](/filings/0001193125-26-144570.md) | Proxy statement, period 2026-05-19 | 0001193125-26-144570 |
| 2026-02-26 | 07:06 ET | [10-K](/filings/0001193125-26-073379.md) | Annual report, period 2025-12-31 | 0001193125-26-073379 |
| 2026-02-26 | 07:05 ET | [8-K](/filings/0001193125-26-073377.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-073377 |
| 2026-01-08 | 16:03 ET | [8-K](/filings/0001193125-26-007660.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-007660 |
| 2026-01-07 | 16:02 ET | [8-K](/filings/0001193125-26-006266.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-006266 |
| 2025-11-04 | 17:24 ET | [SCHEDULE 13D/A](/filings/0001231919-25-000418.md) | Ownership report, active investor, amended | 0001231919-25-000418 |
| 2025-11-04 | 07:05 ET | [8-K](/filings/0001193125-25-263534.md) | 8.01 Other events | 0001193125-25-263534 |
| 2025-10-30 | 07:05 ET | [10-Q](/filings/0001193125-25-257390.md) | Quarterly report, period 2025-09-30 | 0001193125-25-257390 |
| 2025-10-30 | 07:00 ET | [8-K](/filings/0001193125-25-257382.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-257382 |
| 2025-10-27 | 06:02 ET | [8-K](/filings/0001193125-25-250611.md) | 8.01 Other events | 0001193125-25-250611 |
| 2025-10-06 | 08:05 ET | [8-K](/filings/0001193125-25-230984.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-230984 |
| 2025-08-20 | 17:18 ET | [SCHEDULE 13D/A](/filings/0001415889-25-022496.md) | Ownership report, active investor, amended | 0001415889-25-022496 |
| 2025-08-07 | 07:05 ET | [10-Q](/filings/0000950170-25-104548.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104548 |
| 2025-08-07 | 07:05 ET | [8-K](/filings/0001193125-25-174943.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-174943 |
| 2025-06-16 | 08:05 ET | [8-K](/filings/0001193125-25-141119.md) | 8.01 Other events | 0001193125-25-141119 |
| 2025-06-09 | 16:01 ET | [8-K](/filings/0001193125-25-137800.md) | 5.07 Shareholder vote results | 0001193125-25-137800 |
| 2025-06-06 | 16:23 ET | [8-K](/filings/0001193125-25-137094.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-137094 |
| 2025-05-13 | 16:22 ET | [SCHEDULE 13D/A](/filings/0001415889-25-012779.md) | Ownership report, active investor, amended | 0001415889-25-012779 |
| 2025-05-01 | 07:05 ET | [10-Q](/filings/0000950170-25-061440.md) | Quarterly report, period 2025-03-31 | 0000950170-25-061440 |
| 2025-05-01 | 07:05 ET | [8-K](/filings/0001193125-25-108726.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-108726 |
| 2025-04-23 | 16:03 ET | [DEF 14A](/filings/0000950170-25-057326.md) | Proxy statement, period 2025-06-03 | 0000950170-25-057326 |
| 2025-04-16 | 08:06 ET | [8-K](/filings/0001193125-25-082089.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-082089 |
| 2025-04-01 | 08:17 ET | [8-K](/filings/0001193125-25-069748.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-069748 |
| 2025-03-06 | 08:05 ET | [8-K](/filings/0001193125-25-047882.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-047882 |
| 2025-03-06 | 08:05 ET | [10-K](/filings/0000950170-25-034183.md) | Annual report, period 2024-12-31 | 0000950170-25-034183 |
| 2024-12-11 | 08:05 ET | [8-K](/filings/0001193125-24-274876.md) | 8.01 Other events | 0001193125-24-274876 |
| 2024-11-07 | 16:05 ET | [10-Q](/filings/0000950170-24-123264.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123264 |
| 2024-11-07 | 08:05 ET | [8-K](/filings/0001193125-24-252642.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-252642 |
| 2024-08-22 | 16:05 ET | [SC 13D/A](/filings/0001193125-24-205352.md) | Ownership report, active investor, amended | 0001193125-24-205352 |
| 2024-08-19 | 17:13 ET | [8-K](/filings/0001193125-24-202879.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-202879 |
| 2024-08-08 | 16:05 ET | [10-Q](/filings/0000950170-24-093885.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093885 |
| 2024-08-08 | 08:06 ET | [8-K](/filings/0001193125-24-196506.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-196506 |
| 2024-07-18 | 08:05 ET | [8-K](/filings/0001193125-24-180750.md) | 8.01 Other events | 0001193125-24-180750 |
| 2024-06-14 | 16:05 ET | [10-K/A](/filings/0000950170-24-073629.md) | Annual report, amended, period 2023-12-31 | 0000950170-24-073629 |
| 2024-06-14 | 16:05 ET | [10-Q/A](/filings/0000950170-24-073628.md) | Quarterly report, amended, period 2024-03-31 | 0000950170-24-073628 |
| 2024-06-06 | 13:59 ET | [SC 13D/A](/filings/0001193125-24-155898.md) | Ownership report, active investor, amended | 0001193125-24-155898 |
| 2024-05-24 | 16:03 ET | [8-K](/filings/0001193125-24-147017.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-24-147017 |
| 2024-05-09 | 16:06 ET | [10-Q](/filings/0000950170-24-056888.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056888 |
| 2024-05-09 | 08:05 ET | [8-K](/filings/0001193125-24-134793.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-134793 |

Page 1 of 4. [Older](/companies/phat/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:19 ET. No prices; not investment advice.